Budel L M, Delwel R, van Buitenen C, Hoogerbrugge H, Löwenberg B
Dr Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.
Leukemia. 1993 Mar;7(3):426-34.
We have investigated the stimulative effects of mast cell growth factor (MGF) in primary acute myeloid leukemia (AML) in vitro. MGF stimulated DNA synthesis of purified leukemic blasts in eight out of 10 cases and colony formation in four cases in serum-free (SF) culture. MGF synergized with interleukin-3 (IL-3; four out of 10 cases), granulocyte-macrophage colony-stimulating factor (GM-CSF; three out of 10 cases), granulocyte colony-stimulating factor (G-CSF; six out of 10 cases), macrophage colony-stimulating factor (M-CSF; one out of 10 cases) and erythropoietin (EPO; one out of 10 cases) when added to culture in combination. Synergistic effects of MGF in combination with other CSFs were also seen in the colony assay. Antibodies against GM-CSF, M-CSF, G-CSF, and IL-6 did not inhibit the MGF response, suggesting that the stimulative effect of MGF was not mediated through autocrine release of those cytokines. Cell recovery data in liquid cultures that contained MGF, IL-3, or MGF + IL-3, indicated that both MGF and IL-3 augmented the maintenance of clonogenic cells as compared to nonsupplemented cultures, but the effect of the combination of IL-3 + MGF did not show synergy. In contrast, activation of DNA synthesis by MGF was abrogated in the presence of tumor necrosis factor (TNF; four out of 10 cases) and interleukin-4 (IL-4; two out of 10 cases). Fluorescence-activated cell sorting (FACS) analysis with anti c-kit antibodies revealed MGF receptor expression in eight out of nine cases, often in a subpopulation of the cells. Scatchard analysis of MGF receptors in two cases indicated the presence of 1460 and 41,500 (mean) binding sites, respectively, of high affinity (Kd 40-160 pmol/l). The MGF dose-response curve in the presence of IL-3 or GM-CSF resulted in a higher plateau of DNA synthesis, however no shift in the dose response was apparent. The respective reciprocal dose response relations to GM-CSF, IL-3, or G-CSF were similarly elevated when MGF was added. MGF did not alter IL-3 and GM-CSF receptor expression, nor did IL-3, GM-CSF, G-CSF, TNF, or IL-4 influence MGF binding to AML cells.(ABSTRACT TRUNCATED AT 400 WORDS)
我们研究了肥大细胞生长因子(MGF)在原发性急性髓系白血病(AML)体外实验中的刺激作用。在无血清(SF)培养中,MGF刺激了10例中的8例纯化白血病原始细胞的DNA合成以及4例的集落形成。MGF与白细胞介素-3(IL-3;10例中的4例)、粒细胞-巨噬细胞集落刺激因子(GM-CSF;10例中的3例)、粒细胞集落刺激因子(G-CSF;10例中的6例)、巨噬细胞集落刺激因子(M-CSF;10例中的1例)和促红细胞生成素(EPO;10例中的1例)联合添加到培养物中时具有协同作用。在集落测定中也观察到MGF与其他集落刺激因子联合时的协同效应。抗GM-CSF、M-CSF、G-CSF和IL-6抗体不抑制MGF反应,这表明MGF的刺激作用不是通过这些细胞因子的自分泌释放介导的。含有MGF、IL-3或MGF + IL-3的液体培养中的细胞恢复数据表明,与未添加的培养相比,MGF和IL-3均增强了克隆形成细胞的维持,但IL-3 + MGF组合的效果未显示出协同作用。相反,在存在肿瘤坏死因子(TNF;10例中的4例)和白细胞介素-4(IL-4;10例中的2例)的情况下,MGF对DNA合成的激活作用被消除。用抗c-kit抗体进行的荧光激活细胞分选(FACS)分析显示,9例中的8例存在MGF受体表达,且通常在细胞亚群中。对2例中的MGF受体进行Scatchard分析表明,分别存在1460个和41500个(平均)高亲和力(Kd 40 - 160 pmol/l)结合位点一。在存在IL-3或GM-CSF的情况下,MGF的剂量反应曲线导致DNA合成的平台更高,但剂量反应没有明显偏移。当添加MGF时,与GM-CSF、IL-3或G-CSF各自的倒数剂量反应关系同样升高。MGF不改变IL-3和GM-CSF受体表达,IL-3、GM-CSF、G-CSF、TNF或IL-4也不影响MGF与AML细胞的结合。(摘要截短至400字)